Patients with (CFS) exhibited significantly lower levels of several compared to Healthy Controls.
CFS patients showed reduced gut microbiota diversity and altered microbial community structure.
Fecal concentrations of acetate, butyrate, isobutyrate, and isovalerate were significantly lower in the CFS group.
Key microbial taxa associated with SCFA production, such as Firmicutes and Ruminococcaceae, were significantly reduced in CFS patients.
Positive correlations were found between specific SCFA-producing bacteria and butyrate levels, indicating a link to SCFA metabolism.
Lower abundances of certain taxa were associated with increased fatigue scores and decreased quality of life in CFS patients.
Higher dietary fiber intake was linked to increased levels of acetate and isovalerate in CFS patients.
Simplified
To investigate differences in gut microbiota composition and (SCFAs) metabolism between patients with (CFS) and Healthy Controls (HC), and to explore their associations with the CFS pathogenesis. This case-control study included 80 subjects, comprising 40 patients with CFS and 40 age- and sex-matched HC. Fecal microbial community structure was analyzed using 16S rRNA gene high-throughput sequencing. Fecal SCFAs concentrations were quantified using Gas Chromatography-Mass Spectrometry (GC-MS). Spearman correlation analysis with false discovery rate (FDR) adjustment was performed to elucidate associations among gut microbiota, SCFAs, and clinical scores. Compared to the HC group, the CFS group exhibited reduced gut microbiota α-diversity (e.g., ACE, Chao1, Shannon indices, all P < 0.01) and significantly altered β-diversity (ADONIS, P = 0.006). After FDR adjustment, fecal levels of acetate, butyrate, isobutyrate, and isovalerate remained significantly lower in the CFS group (all q < 0.05). Differential abundance analysis revealed a significant reduction in key taxa including the phylum Firmicutes (q = 0.010), class Verrucomicrobiae (q = 0.038), order Clostridiales (q = 0.043), and families Rikenellaceae (q = 0.011) and Ruminococcaceae (q = 0.049). Spearman correlation analysis solidified functional connections: key SCFA-producing taxa (e.g., Faecalibacterium, Subdoligranulum, Ruminococcaceae) were positively correlated with butyrate levels (r = 0.52-0.56, all q < 0.05). Furthermore, reduced abundances of Rikenellaceae and Alistipes were associated with lower SF-36 scores (r = 0.26, q = 0.032) and higher fatigue scores (FSS/FS-14, r = - 0.28 to - 0.30, q < 0.05). Isovalerate levels were negatively correlated with FS-14 scores (r = - 0.307, q = 0.014). Among CFS patients, those with higher dietary fiber intake had significantly higher levels of acetate and isovalerate than those with lower intake (both q < 0.05). Patients with CFS exhibit significant gut dysbiosis and abnormal SCFA metabolism. The reduction in key SCFA-producing taxa, their positive correlations with SCFAs levels, and the negative correlations of both with fatigue severity solidify a functional link between gut microbial depletion, reduced SCFAs, and clinical symptoms in CFS. Higher dietary fiber intake may partially ameliorate SCFAs metabolic disturbances in CFS patients.
Key numbers
all q < 0.05
Decrease in SCFA Levels
Fecal concentrations of key were significantly reduced in patients.
16 of 40
Patients with Higher Fiber Intake
patients were divided based on dietary fiber intake, with 16 in the high-fiber group.
Full Text
We can’t show the full text here under this license.
Declarations. Competing interests: The authors declare no competing interests. Ethical approval and informed consent: This research protocol was approved by the Medical Ethics Committee of the Affiliated Hospital of Shandong University of Traditional Chinese Medicine (approval number: (2023) Lunshen No. (053)-KY), and strictly followed the ethical guidelines of the Declaration of Helsinki. All participants signed a written informed consent form.
